IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Emec who wrote (1139)	11/3/1998 11:14:00 AM
From: jake burns	Read Replies (2) of 1510

Most stocks do not go up upon fda approval. Rather, they run in advance of the approval...investors anticipate that it will happen. Same thing will occur with Remune. When the application is made, this baby's going to run. I think we'll be over 30 dollars by year-end, based on great RA data being released. I forget the name of IMNR's ra drug...it's going to be called Zybac or something like that...anyway, it's not toxic like enbrel, is easier to administer, and intervenes in the disease process at an earlier stage. The 14 dollar range has been a very important resistance point. Once we punch through this, I think we will go on a nice run. Good luck all.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next